Medical news

Researchers are making advances in chemotherapy, immunotherapy, radiotherapy, and other techniques.

Alimta may be pulled from use in Britain because of expense

Some controversey in the UK and a little tension between the medical establishments in Scotland and England. The Scottish Medicines Consortium approved alimta for mesothelioma treatment last year, but now the UK’s National Institute for Health and Clinical Excellence, based in England, is saying the drug is too expensive. According to this article, “It is …

Alimta may be pulled from use in Britain because of expense Read More »

Another milestone for Onconase

Alfacell Corp., the New Jersey pharmaceutical company, got enough patients to go ahead with phase IIIb testing on Onconase, (ranpirnase). Another step in the long process toward getting approval for that drug, which is promising in mesothelioma treatment. The drug companies sometimes target mesothelioma in their development process even though it is a rare form …

Another milestone for Onconase Read More »

B-reader consistency?

Impact Analysis blog talks about the integrity of B Readers as expert witnesses in occupational health court cases. NIOSH B Reader approval is granted to physicians who demonstrate proficiency in the classification of chest radiographs for the pneumoconioses using the International Labour Office (ILO) Classification System. Mesothelioma Aid’s write-up on B-readers is here. This is …

B-reader consistency? Read More »